BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8324795)

  • 1. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide.
    Toombs CF; Moore TL; Shebuski RJ
    Cardiovasc Res; 1993 Apr; 27(4):617-22. PubMed ID: 8324795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channels.
    Toombs CF; McGee DS; Johnston WE; Vinten-Johansen J
    Cardiovasc Res; 1993 Apr; 27(4):623-9. PubMed ID: 8324796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium.
    Walsh RS; Tsuchida A; Daly JJ; Thornton JD; Cohen MV; Downey JM
    Cardiovasc Res; 1994 Sep; 28(9):1337-41. PubMed ID: 7954642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart.
    Fralix TA; Steenbergen C; London RE; Murphy E
    Cardiovasc Res; 1993 Apr; 27(4):630-7. PubMed ID: 8324797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate.
    Auchampach JA; Grover GJ; Gross GJ
    Cardiovasc Res; 1992 Nov; 26(11):1054-62. PubMed ID: 1291082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischaemic preconditioning delays ischaemia induced cellular electrical uncoupling in rabbit myocardium by activation of ATP sensitive potassium channels.
    Tan HL; Mazón P; Verberne HJ; Sleeswijk ME; Coronel R; Opthof T; Janse MJ
    Cardiovasc Res; 1993 Apr; 27(4):644-51. PubMed ID: 8324799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial ischemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide.
    Elliott GT; Comerford ML; Smith JR; Zhao L
    Cardiovasc Res; 1996 Dec; 32(6):1071-80. PubMed ID: 9015409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are ATP sensitive potassium channels involved in the pronounced antiarrhythmic effects of preconditioning?
    Vegh A; Papp JG; Szekeres L; Parratt JR
    Cardiovasc Res; 1993 Apr; 27(4):638-43. PubMed ID: 8324798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitation of myocardial infarct size in the rabbit by ischaemic preconditioning is abolished by sodium 5-hydroxydecanoate.
    Hide EJ; Thiemermann C
    Cardiovasc Res; 1996 Jun; 31(6):941-6. PubMed ID: 8759250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effects of nicorandil in rabbits anaesthetized with halothane: potentiation of ischaemic preconditioning via KATP channels.
    Nakae I; Takaoka A; Mitsunami K; Yabe T; Ito M; Masayuki ; Takahashi ; Matsumoto T; Omura T; Yokohama H; Kinoshita M
    Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):810-7. PubMed ID: 11022974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning.
    Jenkins DP; Pugsley WB; Yellon DM
    J Mol Cell Cardiol; 1995 Aug; 27(8):1623-32. PubMed ID: 8523425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The K(ATP) channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbits.
    Jung O; Englert HC; Jung W; Gögelein H; Schölkens BA; Busch AE; Linz W
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):445-51. PubMed ID: 10763861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion.
    Sheldrick A; Gray KM; Drew GM; Louttit JB
    Br J Pharmacol; 1999 Sep; 128(2):385-95. PubMed ID: 10510449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protection of ischaemic preconditioning can be reinstated in the rabbit heart after the initial protection has waned.
    Yang XM; Arnoult S; Tsuchida A; Cope D; Thornton JD; Daly JF; Cohen MV; Downey JM
    Cardiovasc Res; 1993 Apr; 27(4):556-8. PubMed ID: 8324785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels.
    Hide EJ; Ney P; Piper J; Thiemermann C; Vane JR
    Br J Pharmacol; 1995 Nov; 116(5):2435-40. PubMed ID: 8581281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1-induced reduction of myocardial infarct size by activation of ATP-sensitive potassium channels in a rabbit model of myocardial ischaemia and reperfusion.
    Hide EJ; Piper J; Thiemermann C
    Br J Pharmacol; 1995 Nov; 116(6):2597-602. PubMed ID: 8590976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac protection by ischaemic preconditioning is not mediated by myocardial stunning.
    Matsuda M; Catena TG; Vander Heide RS; Jennings RB; Reimer KA
    Cardiovasc Res; 1993 Apr; 27(4):585-92. PubMed ID: 8324790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: reduction of myocardial infarct size with an acute memory phase.
    Kersten JR; Schmeling TJ; Pagel PS; Gross GJ; Warltier DC
    Anesthesiology; 1997 Aug; 87(2):361-70. PubMed ID: 9286901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits.
    Burckhartt B; Yang XM; Tsuchida A; Mullane KM; Downey JM; Cohen MV
    Cardiovasc Res; 1995 May; 29(5):653-7. PubMed ID: 7606753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.